Citable filing context

AFL filing events and research context

Server-rendered

AFL's research view summarizes recent SEC filing context, starting with mda_quarterly from May 6, 2026.

AFL filing events and research context
FiledItemContext
May 6, 2026mda_quarterlyAflac reported net earnings of $1.0 billion ($1.98 per diluted share) for the first quarter of 2026, a significant increase from $29 million ($0.05 per diluted share) in the first quarter of 2025. This improvement was primarily driven by a swing from $963 million in net investment losses in 2025 to $49 million in net investment gains in 2026. Adjusted earnings remained stable at $901 million, though the 2.8% weakening of the yen against the dollar negatively impacted adjusted earnings per diluted share by $0.02. The company’s insurance operations are divided into Aflac Japan and Aflac U.S., both focusing on supplemental health and life insurance. Aflac Japan continues to represent the majority of the company's assets (76%). Investment performance remains a critical driver, with a portfolio heavily weighted toward fixed maturity securities. The company maintains a $10.2 billion commercial mortgage and other loan portfolio, which includes transitional real estate loans and middle market loans. Management noted a $61 million increase in credit loss allowances and $24 million in real estate impairments during the quarter. Aflac continues to actively manage capital, repurchasing $1.0 billion in common stock during the first three months of 2026, with 105.3 million shares remaining under current authorization.
Feb 25, 2026businessAflac operates as a major provider of supplemental health and life insurance, with primary markets in Japan and the United States. The company specializes in cancer policies in Japan and offers a mix of individual and group insurance products in the U.S. A critical component of its Japanese operations is a strategic alliance with Japan Post Network. Due to its significant international footprint, Aflac faces substantial foreign currency risk, specifically regarding the Japanese yen, which it manages through foreign currency forward contracts to hedge net investments in Aflac Japan. Solvency and capital adequacy are monitored via the Economic Solvency Ratio (ESR) and Solvency Margin Ratio (SMR) in Japan, and the Risk-based Capital (RBC) ratio in the U.S. As of 2025, the company reported $245.6 billion in life insurance in force. Financial stability is supported by a diverse portfolio of fixed maturity securities and a structured debt profile consisting of various senior notes and subordinated debentures. Key operational metrics for analysts include annualized premiums in force, premium persistency, and new money yield on invested assets.
Feb 25, 2026mdaAflac’s 2025 total revenues declined 9.3% to $17.2 billion, with net earnings falling to $3.6 billion, primarily driven by $572 million in net investment losses compared to gains in 2024. Adjusted earnings remained stable at $4.0 billion. The company repurchased $3.5 billion in common shares and announced a 5.2% quarterly dividend increase for 2026. A significant operational risk emerged from a June 2025 cybersecurity incident involving the exfiltration of personal data from 22.65 million U.S. individuals; however, management does not expect a material financial impact. In Japan, Aflac is capitalizing on an aging population through "third sector" cancer and medical products, notably the Miraito product, while expanding "first sector" retirement offerings like Tsumitasu. The U.S. segment is focusing on group products and diversifying its customer base toward millennials. For 2026, Aflac targets a Japan benefit ratio of 60%–63% and a U.S. benefit ratio of 48%–52%. Investment risks include volatility in the yen/dollar exchange rate and exposure to commercial real estate, specifically office properties, which led to $10 million in losses from foreclosures in 2025.

Source: SEC EDGAR filing text and events; period May 6, 2026; filed May 6, 2026.

Continue research

Keep researching AFL

Follow same-sector companies and source explainers connected to the research view.

Related tickers

BRK-B
Berkshire Hathaway
$1.05T
Financials
Open company page →
JPM
JPMorgan Chase
$833.64B
Financials
Open company page →
V
Visa Inc.
$607.99B
Financials
Open company page →
MA
Mastercard
$429.11B
Financials
Open company page →
BAC
Bank of America
$380.41B
Financials
Open company page →
MS
Morgan Stanley
$334.67B
Financials
Open company page →

Related explainers

Understanding 8-K filings

A factual guide to SEC Form 8-K current reports and the material company events they can disclose between quarterly filings.

Read explainer →
Reading a 10-Q

A factual guide to quarterly SEC Form 10-Q reports, how they differ from annual 10-K filings, and what readers can inspect first.

Read explainer →
S-1 and the IPO prospectus

A factual guide to Form S-1 registration statements and the disclosures companies provide before a public offering.

Read explainer →
Reading an SEC 10-K

A factual guide to the core 10-K sections investors use for company context: business description, risk factors, MD&A, financial statements, and segment disclosures.

Read explainer →